EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Genetic Characterization of Russian Patients with von Hippel–Lindau Syndrome

Dmitry S Mikhaylenko iD, Natalya N Vasserman, Natalya B Kuryakova iD, Ekaterina B Kuznetsova iD, Nina A Gorban, Anna A Stepanova iD, Olga A Shchagina iD, Alexander V Polyakov, Dmitry V Zaletaev iD, Sergey I Kutsev, Vladimir V Strelnikov iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dmitry S Mikhaylenko und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moscow 115522, Russia. Hauptthemen laut MEDLINE: von Hippel-Lindau Disease, Von Hippel-Lindau Tumor Suppressor Protein. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Von Hippel–Lindau syndrome (VHLS) is an autosomal dominant hereditary cancer disease caused by germline mutations in the VHL tumor suppressor gene and characterized by clinical heterogeneity and phenotype–genotype associations. We studied the VHL gene in 535 Russian patients referred for VHLS diagnostics using Sanger sequencing, multiplex ligase-dependent probe amplification, and, in some cases, high-throughput sequencing. A total of 177 causative VHL variants were identified, including 129 point mutations and 48 extended deletions. Missense variants were the most frequent (60.3%) and predominantly localized at codons 167, 88, and 78. Approximately 88% of the analyzed missense variants and in-frame indels led to changes directly at the HIF-α- and ELOC-binding sites of pVHL. Patients with causative VHL variants had CNS hemangioblastoma (69.7%), retinal hemangioblastomas (41.4%), clear-cell renal carcinoma (CCRC) (27.3%), renal cysts (22.2%), pancreatic cysts (20.2%), and pheochromocytoma (7.1%). The frequency of multiple pathological changes in targeted organs was significantly higher in patients with causative variants than in the group without mutations, at 78.8% versus 21.1% (p < 0.0001), whereas a single case of CCRC, even in adults under 60 years of age, had a low positive predictive value (14.7%) in relation to P/LP variant detection. The variant c.208G>A;p.Glu70Lys was identified in four patients of East Asian ancestry only; the nonsense variant c.481C>T;p.Arg161* was found significantly more frequently in patients of Turkic ethnicities than in Slavic patients: 30.0 versus 2.5% (p = 0.0047). We did not identify significant differences in the profile of causative germline variants and frequencies of various VHLS clinical manifestations in our cohort compared with other Slavic people. Also, we examined 87 relatives of probands and identified 41 carriers of the causative variants. The obtained results may contribute to improving the diagnosis of VHLS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Hippel-Lindau DiseaseVon Hippel-Lindau Tumor Suppressor ProteinHumansFemaleRussiaMiddle AgedAdultMaleGerm-Line MutationAdolescentYoung AdultAgedGenetic Association Studies

Stichwörter der Autor:innen

VHL genegermline variantrenal cancersequencingvon Hippel–Lindau syndrome

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinVHL protein, human

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, Moscow 115522, Russia.
  • Department of Translational Medicine and Biotechnology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia.
  • A.F. Tsyb Medical Radiological Research Center-Branch of the National Medical Research Center of Radiology, Obninsk 249036, Russia.

ORCID-Profile: Dmitry S Mikhaylenko, Natalya B Kuryakova, Ekaterina B Kuznetsova, Anna A Stepanova, Olga A Shchagina, Dmitry V Zaletaev, Vladimir V Strelnikov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Mikhaylenko, D. S., Vasserman, N. N., Kuryakova, N. B., Kuznetsova, E. B., Gorban, N. A., Stepanova, A. A., Shchagina, O. A., Polyakov, A. V., Zaletaev, D. V., Kutsev, S. I., & Strelnikov, V. V. (2026). Clinical and Genetic Characterization of Russian Patients with von Hippel–Lindau Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198804

Vancouver

Mikhaylenko DS, Vasserman NN, Kuryakova NB, Kuznetsova EB, Gorban NA, Stepanova AA, et al. Clinical and Genetic Characterization of Russian Patients with von Hippel–Lindau Syndrome. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198804

BibTeX
@article{Mikhaylenko2026,
  author = {Mikhaylenko, Dmitry S and Vasserman, Natalya N and Kuryakova, Natalya B and Kuznetsova, Ekaterina B and Gorban, Nina A and Stepanova, Anna A and Shchagina, Olga A and Polyakov, Alexander V and Zaletaev, Dmitry V and Kutsev, Sergey I and Strelnikov, Vladimir V},
  title = {Clinical and Genetic Characterization of Russian Patients with von Hippel–Lindau Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198804}
}
Kostenlos starten →